This activation inhibits VEGF-induced angiogenesis in specific cancer cells, such as uveal melanoma UM92.1 cells and PC-3 cells, providing a novel approach to target angiogenesis in cancer therapy (62–64). This evidence concerns the gene VEGFA and cancer.